Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the powerful anesthetic ketamine can save patients from prolonged, life-threatening seizures. (Illustration by John DiJulio, University Communications)

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of research suggesting it can be especially effective against types

The University of Virginia (UVA) is spearheading a nationwide clinical trial exploring a new treatment option for prolonged seizures.

Why We Need Fast-Acting Anxiety Relief Now More Than Ever Anxiety isn’t just feeling nervous before a big event—it can be relentless, overwhelming, and even debilitating. Traditional treatments like SSRIs and talk therapy can be effective for many,

So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the Misuse of Drugs to “carefully consider” the issue. Do you think ketamine should count as a Class A drug? Vote on our poll to tell us how how feel about this issue.

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year than those who reported no past-year drug use.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous narcotics operation spanning two boroughs.

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what they've said

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term complications.

They've found recreational use has grown dramatically over the past decade. It increased more than 80 percent from 2015 to 2019 and another 40 percent from 2021 to 2022. For experts, those numbers are alarming because the people consuming the drug may not know the serious risks associated with unsupervised use.

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental health conditions. However, they may cover the FDA-approved nasal spray, Spravato, which contains a derivative of ketamine called esketamine.